<?xml version="1.0" encoding="UTF-8"?>
<ref id="B73">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Satoh</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Toyota</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ikeda</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Morimoto</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Akino</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Mita</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Suzuki</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sasaki</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kanaseki</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Takamura</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Soejima</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Urano</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Yanagihara</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Endo</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Hinoda</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Fujita</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hosokawa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sato</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Tokino</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Imai</surname>
    <given-names>K.</given-names>
   </name>
  </person-group> (
  <year>2004</year>). 
  <article-title>Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells</article-title>. 
  <source>Oncogene</source>
  <volume>23</volume>, 
  <fpage>8876</fpage>â€“
  <lpage>8886</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.onc.1208144</pub-id>
  <pub-id pub-id-type="pmid">15467734</pub-id>
 </mixed-citation>
</ref>
